Default company panoramic image
Logo

Radisens Diagnostics

Develops point-of-care device & test panels for instant blood diagnosis of diabetes, heart disease, kidney/liver disease, cardiac, cancers..

  • Stage $500K in TTM Revenue
  • Industry Medical Devices and Equipment
  • Location Ireland
  • Currency EUR
  • Employees 12
  • Website radisens.com

Company Summary

Radisens is a medical diagnostics SME with a mission to become the leading diagnostics solution at point-of-care. Its disruptive lab-grade device integrates three families of blood tests onto multiplexed test panels using a drop of blood with results within minutes. Our initial tests into physician offices cover chronic conditions including diabetes, heart disease, thyroid and liver function and kidney disease, with plans for cancer and cardiac.

Team

  • Default avatar
    Jerry O'Brien
    CEO
    Unconfirmed

    Jerry founded Radisens in 2009 with 17 years consumer electronics experience, holding senior commercial and product development roles in various startup and high growth tech companies focused in Far East, US and EU markets. He was Marketing Director at Frontier Silicon, responsible for broadcast TV and wireless platforms into mobile phone markets. Beforehand, we was head of business development, Wireless Division at Parthus Technologies.

  • Default avatar
    Ian Hayes
    Business Development
    Unconfirmed

    With a background in diagnostics, biochemistry and drug discovery, Dr Ian Hayes has 17 years commercial and business development experience in partnering, deal negotiation and licensing of multi-million €uro contracts. Having worked with many startup and early stage life science companies including Opsona, Alimentary Health, Crescent Diagnostics, and Eirx Therapeutics, Ian has consistently managed and delivered upon aggressive revenue targets.

  • Default avatar
    Eoin O'Nuallain
    Chief Scientist
    Unconfirmed

    Dr. Eoin O’Nualláin has 25 years diagnostic industry experience within point-of-care diagnostic startup and multinationals, most recently being R&D Manager for the Infectious Disease Division at Trinity Biotech, where he delivered three generations of the HIV lateral flow diagnostic assays into mass production.

  • Default avatar
    Lee Barry
    Engineering Director
    Unconfirmed

    Lee Barry has 17 years semiconductor industry experience having held various senior engineering, operations and management roles through multiple company growth phases, most recently being Engineering Director with Ceva DSP Group. Lee worked as a bioelectronics research engineer before joining Parthus from startup in 1995, progressing through various senior design and project management roles.

  • Default avatar
    Greg Kellogg
    Product Development Director
    Unconfirmed

    Greg is an internationally recognised pioneer of centrifugal micro-fluidics with a strong track record of innovative technology development, and building R&D organizations while at Gamera, Tecan, Network Biosystems and Protiveris. Thru his 20 year career, he has developed novel microfluidic technologies with applications in genotyping, molecular and clinical diagnostics, drug discovery, and forensics, developing disposables & instrumentation.

Advisors

  • Default avatar
    Adrian Wall, Partner, Ronan Daly Jermyn, South Mall, Cork
    Lawyer
    Unconfirmed
    Default avatar
    Ciaran Walsh, OFM Solutions, Blackrock, Co. Dublin
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Promoter, Private Angels, Sophia Business Angels (France)
    Unconfirmed
    Default avatar
    Top 3 US Academic Institution
    Unconfirmed
    Default avatar
    Kernel Capital
    Unconfirmed